10-Q: U.S. Physical Therapy Reports Strong First Quarter 2025 Results Driven by Acquisitions and Increased Patient Revenue

U.S. Physical Therapy, Inc. announces a robust first quarter for 2025, marked by revenue growth from strategic acquisitions and improved patient service rates.

Summary

• U.S. Physical Therapy, Inc. reported a net patient revenue increase of 16.4% to $152.5 million for the first quarter of 2025.
• Total net revenue rose by 18.1% to $183.8 million compared to $155.7 million in the same period last year.
• The company's operating costs increased by 20.0% to $152.7 million.
• Gross profit reached $31.1 million, representing 16.9% of net revenue.
• Net income attributable to USPH shareholders was $9.9 million, or $0.80 per share, compared to $8.0 million, or $0.46 per share, in the first quarter of 2024.
• Adjusted EBITDA increased by 16.5% to $19.5 million.
• The company acquired a 65% interest in a physical therapy practice with three clinic locations in February 2025.
• The Board of Directors declared a quarterly dividend of $0.45 per share, payable on June 13, 2025.
• As of March 31, 2025, the company operated and/or managed 736 clinics in 44 states, and also managed 37 hospital and/or physician owned physical therapy practices.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and strategic growth initiatives. The company's performance is solid, and the management seems confident in future prospects.

Positives

• The company experienced significant revenue growth in both its physical therapy and industrial injury prevention services segments.
• Net rate per patient visit increased, indicating improved pricing and service mix.
• Adjusted EBITDA showed substantial growth, reflecting improved operational efficiency.
• The company continues to expand through strategic acquisitions.
• The declaration of a quarterly dividend reflects confidence in the company's financial performance.
• The company is in compliance with all covenants contained in the Credit Agreement.

Negatives

• Operating costs increased, although revenue growth outpaced cost increases.
• Interest income from investments decreased significantly due to the deployment of cash into acquisitions.
• Operating Results, a non-GAAP measure, was $7.3 million in the 2025 First Quarter compared to $7.7 million in the 2024 First Quarter.

Risks

• Changes in Medicare reimbursement rates could negatively impact revenue.
• The company is subject to various legal actions and regulatory audits.
• The ability to hire and retain qualified physical therapists is crucial for maintaining service quality.
• Economic conditions, including inflationary and recessionary periods, could affect business performance.
• Cybersecurity breaches could disrupt operations and compromise patient data.
• The company's debt and financial obligations could adversely affect its financial condition.

Future Outlook

The company plans to continue acquiring outpatient physical therapy practices, developing satellite clinics, and acquiring companies in the industrial injury prevention sector.

Industry Context

The physical therapy industry is experiencing growth due to an aging population, increasing prevalence of chronic conditions, and rising demand for rehabilitation services. U.S. Physical Therapy's strategic acquisitions and focus on expanding its service offerings align with these industry trends. Competitors include large national chains like ATI Physical Therapy and Select Medical, as well as numerous regional and local providers. U.S. Physical Therapy differentiates itself through its partnership model with clinic directors, which fosters a strong entrepreneurial culture and local market expertise.

Comparison to Industry Standards

• U.S. Physical Therapy's revenue growth of 18.1% is strong compared to the industry average, which is estimated to be in the single digits.
• The company's Adjusted EBITDA margin of approximately 10.6% is competitive with other publicly traded rehabilitation companies.
• ATI Physical Therapy, a major competitor, has faced financial challenges in recent years, highlighting the importance of U.S. Physical Therapy's disciplined acquisition strategy and focus on profitability.
• Select Medical, another key player, operates a broader range of healthcare services, including inpatient rehabilitation, which provides diversification but also different operational dynamics.

Legal Proceedings

• The company is a party to various legal actions, proceedings, and claims in the ordinary course of business.
• Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act.

Related Party Transactions

• The Company leases certain properties from Michael G. Mayrsohn (lessor), who is the President of Metro and has been nominated by the Board of Directors to be elected as a director at the Annual Meeting of Shareholders to be held on May 20,2025.
• For the three months ended March 31, 2025, the Company paid a total of $0.1 million of lease payments to Mr. Mayrsohn.
• The total of minimum future rental payments under these related party lease agreements is $3.0 million as of March 31, 2025.

Stakeholder Impact

• Shareholders will benefit from the increased earnings and the declared dividend.
• Employees will likely see continued job security and potential growth opportunities.
• Customers will have access to a wider network of physical therapy clinics and services.
• Suppliers can expect continued business relationships with a growing company.
• Creditors can be reassured by the company's strong financial performance and compliance with debt covenants.

Next Steps

• Continue acquiring outpatient physical therapy practices.
• Develop outpatient physical therapy clinics as satellites in existing partnerships.
• Continue acquiring companies that provide or serve the IIP sector.

Key Dates

Keywords

physical therapy, industrial injury prevention, revenue, EBITDA, acquisitions, Medicare, dividends, clinics